(1R)-1-(3-METHOXYPHENYL)PROPYLAMINE, 95.0%, 100mg

2-(2,4-Dichlorophenyl)cyclopropane-1-carboxylic acid, 97%, 250mg

[(2-fluorophenyl)amino](oxo)acetic acid, 95.0%, 250mg

2-Bromo-4-methylthiazole, 98.0%, 100g

Sodium Anthraquinone-1-sulfonate>98.0%(HPLC)250g

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 0.10 µm, 1 Piece(s)

5,5',5''-(Benzene-1,3,5-triyl)tris(thiophene-2-carbaldehyde), 97%, 250mg

Screw vials free-standing sterile, 0.5 ml, 1000 Piece(s)

4-Bromo-1H-pyrrolo[2,3-c]pyridine, 95.0%, 10g

2-Hydrazinopyrimidine, 98.0%, 100g

Methyl hydrazinecarbimidothioate hydroiodide, 95.0%, 1g

(3-Bromo-4-fluorophenyl)boronic acid, 95.0%, 25g

(R)-4-Benzyl-3-cyanomethylmorpholine, 97.0%, 250mg